218 related articles for article (PubMed ID: 24196835)
1. PDLIM2 regulates transcription factor activity in epithelial-to-mesenchymal transition via the COP9 signalosome.
Bowe RA; Cox OT; Ayllón V; Tresse E; Healy NC; Edmunds SJ; Huigsloot M; O'Connor R
Mol Biol Cell; 2014 Jan; 25(1):184-95. PubMed ID: 24196835
[TBL] [Abstract][Full Text] [Related]
2. Essential function for PDLIM2 in cell polarization in three-dimensional cultures by feedback regulation of the β1-integrin-RhoA signaling axis.
Deevi RK; Cox OT; O'Connor R
Neoplasia; 2014 May; 16(5):422-31. PubMed ID: 24863845
[TBL] [Abstract][Full Text] [Related]
3. Sequestration of PDLIM2 in the cytoplasm of monocytic/macrophage cells is associated with adhesion and increased nuclear activity of NF-kappaB.
Healy NC; O'Connor R
J Leukoc Biol; 2009 Mar; 85(3):481-90. PubMed ID: 19052146
[TBL] [Abstract][Full Text] [Related]
4. [PDLIM2 and Its Role in Oncogenesis--Tumor Suppressor or Oncoprote?].
Maryáš J; Bouchal P
Klin Onkol; 2015; 28 Suppl 2():2S40-6. PubMed ID: 26374157
[TBL] [Abstract][Full Text] [Related]
5. Roles of COP9 signalosome in cancer.
Lee MH; Zhao R; Phan L; Yeung SC
Cell Cycle; 2011 Sep; 10(18):3057-66. PubMed ID: 21876386
[TBL] [Abstract][Full Text] [Related]
6. Structural and biochemical characterization of the Cop9 signalosome CSN5/CSN6 heterodimer.
Birol M; Enchev RI; Padilla A; Stengel F; Aebersold R; Betzi S; Yang Y; Hoh F; Peter M; Dumas C; Echalier A
PLoS One; 2014; 9(8):e105688. PubMed ID: 25144743
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the role of COP9 Signalosome (CSN) subunits in K562; the first link between CSN and autophagy.
Pearce C; Hayden RE; Bunce CM; Khanim FL
BMC Cell Biol; 2009 Apr; 10():31. PubMed ID: 19400951
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk between the NF-kappaB activating IKK-complex and the CSN signalosome.
Orel L; Neumeier H; Hochrainer K; Binder BR; Schmid JA
J Cell Mol Med; 2010 Jun; 14(6B):1555-68. PubMed ID: 19656241
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of COP9 signalosome subunits differentially affects the CSN complex and target protein stability.
Peth A; Berndt C; Henke W; Dubiel W
BMC Biochem; 2007 Dec; 8():27. PubMed ID: 18093314
[TBL] [Abstract][Full Text] [Related]
10. IKK-Mediated Regulation of the COP9 Signalosome via Phosphorylation of CSN5.
Zhang J; Zhao R; Yu C; Bryant CLN; Wu K; Liu Z; Ding Y; Zhao Y; Xue B; Pan ZQ; Li C; Huang L; Fang L
J Proteome Res; 2020 Mar; 19(3):1119-1130. PubMed ID: 31950832
[TBL] [Abstract][Full Text] [Related]
11. PDLIM7 Synergizes With PDLIM2 and p62/Sqstm1 to Inhibit Inflammatory Signaling by Promoting Degradation of the p65 Subunit of NF-κB.
Jodo A; Shibazaki A; Onuma A; Kaisho T; Tanaka T
Front Immunol; 2020; 11():1559. PubMed ID: 32849529
[TBL] [Abstract][Full Text] [Related]
12. PDLIM2 Is a Marker of Adhesion and β-Catenin Activity in Triple-Negative Breast Cancer.
Cox OT; Edmunds SJ; Simon-Keller K; Li B; Moran B; Buckley NE; Bustamante-Garrido M; Healy N; O'Flanagan CH; Gallagher WM; Kennedy RD; Bernards R; Caldas C; Chin SF; Marx A; O'Connor R
Cancer Res; 2019 May; 79(10):2619-2633. PubMed ID: 30885980
[TBL] [Abstract][Full Text] [Related]
13. The COP9 signalosome mediates beta-catenin degradation by deneddylation and blocks adenomatous polyposis coli destruction via USP15.
Huang X; Langelotz C; Hetfeld-Pechoc BK; Schwenk W; Dubiel W
J Mol Biol; 2009 Aug; 391(4):691-702. PubMed ID: 19576224
[TBL] [Abstract][Full Text] [Related]
14. CSN5/JAB1 suppresses the WNT inhibitor DKK1 in colorectal cancer cells.
Jumpertz S; Hennes T; Asare Y; Schütz AK; Bernhagen J
Cell Signal; 2017 Jun; 34():38-46. PubMed ID: 28229932
[TBL] [Abstract][Full Text] [Related]
15. Targeted inactivation of the COP9 signalosome impairs multiple stages of T cell development.
Panattoni M; Sanvito F; Basso V; Doglioni C; Casorati G; Montini E; Bender JR; Mondino A; Pardi R
J Exp Med; 2008 Feb; 205(2):465-77. PubMed ID: 18268034
[TBL] [Abstract][Full Text] [Related]
16. Rig-G negatively regulates SCF-E3 ligase activities by disrupting the assembly of COP9 signalosome complex.
Xu GP; Zhang ZL; Xiao S; Zhuang LK; Xia D; Zou QP; Jia PM; Tong JH
Biochem Biophys Res Commun; 2013 Mar; 432(3):425-30. PubMed ID: 23415865
[TBL] [Abstract][Full Text] [Related]
17. Revisiting the COP9 signalosome as a transcriptional regulator.
Chamovitz DA
EMBO Rep; 2009 Apr; 10(4):352-8. PubMed ID: 19305390
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma.
Wurster KD; Hummel F; Richter J; Giefing M; Hartmann S; Hansmann ML; Kreher S; Köchert K; Krappmann D; Klapper W; Hummel M; Wenzel SS; Lenz G; Janz M; Dörken B; Siebert R; Mathas S
Leukemia; 2017 Mar; 31(3):602-613. PubMed ID: 27538486
[TBL] [Abstract][Full Text] [Related]
19. COP9 signalosome function in the DDR.
Hannss R; Dubiel W
FEBS Lett; 2011 Sep; 585(18):2845-52. PubMed ID: 21510940
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of the human COP9 signalosome.
Lingaraju GM; Bunker RD; Cavadini S; Hess D; Hassiepen U; Renatus M; Fischer ES; Thomä NH
Nature; 2014 Aug; 512(7513):161-5. PubMed ID: 25043011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
